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Abstract--l. Under certain conditions, CA I HIR-l$ (86 Asp + Gly) was inactivated in Gnd. HCl more 
rapidly than normal CA I. 
2. After denaturation in 5.0 M Gnd’ HCI, CA I HIR-1 was reactivated more slowly than normal CA 1. 
3. CA I HIR-1 was precipitated by purified anti-CA I antibodies, under certain conditions, more 
rapidly than normal CA I. 
INTRODUCTION 
Studies on the reactivation of denatured enzymes 
Indicate that all of the information necessary to direct 
the proper refolding of a polypeptide chain into a 
functional protein is contained within its primary 
amino-acid sequence (cf. Anfinsen & Scheraga, 1975). 
It therefore would be of interest to study the effect on 
the refolding of a protein whose primary structure has 
been altered by a mutation which results in an amino- 
acid substitution, since such information would be 
useful in determining the importance of an amino- 
acid residue in the folding efficiency of a particular 
protein. It would also be of interest to see whether 
this substitution results in any alteration in antigenic 
properties. If so, it would suggest that the altered resi- 
due is associated with an antigenic site or sites. In this 
respect, the two human red cell carbonic anhydrase 
isozymes, CA I and CA II, could serve as excellent 
candidates for such studies since not only have their 
primary structures (Andersson et a[., 1972; Lin & 
Deutsch, 1973, 1974; Henderson et al., 1976) and 
three-dimensional structures (Liljas et al., 1972; Kan- 
nan et al., 1975) been determined, but the amino-acid 
substitutions for eight inherited variants of human 
CA I, and one variant of CA II have been reported (cf. 
Tashian & Carter, 1976; Tashian et al., 1980). 
Furthermore, conditions for the nearly complete reac- 
tivation of human CA I and CA II denatured in gua- 
nidine. hydrochloride (Gnd . HCl) have been described 
(Carlsson et al., 1973). 
In the present study, we have examined the refold- 
ing and antigenic properties of a mutant human red 
ceil carbonic anhydrase I, CA I Hiroshima-l (CA I 
HIR-l), in which the amino-acid substitution (86 
Asp-+ Gly) has been determined (Kageoka et al., 
1981). 
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MATERIALS AND METHODS 
Enzyme purification 
Normal CA I and CA I HIR-1 were purified from 
hemolysates of heterozygous individuals by affinity 
chromatography on sulfonamide-bound, CM-Sephadex 
columns as previously described (Osborne & Tashian, 
1975). Further purification was achieved by passing the 
normal and variant enzymes through a DEAE~cellulose 
column equilibrated with 0.024 M Tris-HCl buffer, pH 8.7. 
Protein concentrations were determined spectrophoto- 
metrically at 280 nm assuming an extinction coefficient of 
Ei& = 16.3 for human CA I (Nyman & Lindskog, 1964). 
Inactivation in Gnd. HCI 
The normal and variant enzymes (0.4 mg/ml) were de- 
natured in various concentrations of Gnd. HCI (sequential 
grade, Pierce. Chemical Co., Rockford, Illinois) at 25 or 
37°C in 0.1 M Tris-SO, buffer, pH 7.5. At various time 
intervals, aliquots were removed and assayed for esterase 
activity. 
Reactivation after denaturation in Gnd. HCI 
Reactivation of various concentrations of the normal 
and variant enzymes which had been denatured in 5.0 M, 
Gnd. HCI for 24 hr at 25°C. was initiated by rapid dilution 
to 0.5 M Gnd' HCI in 0.1 M Tris-SO,, pH 7.5, buffer with 
and without dithiothreitol. Aliquots were removed at 
various times and assayed for esterase activity. 
Immunological procedures 
Purified antihuman CA I antibodies were prepared by 
adsorption of rabbit antihuman CA I antisera to purified 
human CA I covalently bound to Sepharose 4B (Porath et 
al., 1967) and eluted with 0.1 M glycine buffer, pH 2.6. The 
antibody preparation was dialyzed against 0.0025 M phos- 
phate buffer, pH 7.4, overnight and its concentration deter- 
mined spectrophotometrically assuming an extinction coef- 
ficient of E: $, = 13.8 at 280 nm (Porter, 1957). 
The precipitation of CA I and CA I HIR-1 with increas- 
ing amounts of antibody was accomplished in reaction 
mixtures containing 0.1 mg/ml enzyme (20 ~1) and 20 ~1 of 
various concentrations of the antibody in 100~1 of 
0.1 Tris-SO, buffer, pH 7.5 or 8.0, incubated at 37°C for 
60min. The immunoreaction mixtures were then centri- 
fuged at 10,000 rpm for 20 min to remove the immunopre- 
cipitates. The supernatant solutions and immunoprecipi- 
tates were then assayed for esterase activity. 
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Fig. 1. Time-course for the inactivation of normal CA I 
and CA I HIR-1 at 25 and 37°C in 1.5 and 
1.6 M Gnd. HCI. Conditions: enzyme concentrations, 
0.4 mg/ml; buffer, 0.1 M Tris-SO,, pH 7.5. CA I (0) CA I 
HIR-1 (o), CA I + CA I HIR-1 (1:1)(a). No curves were 
drawn for CA I HIR-1, 1.6 M Gnd.HCl at 25°C and CA 
I + CA 1 HIR-1, 1.6 M Gnd.HCl at 37°C. 
Time course studies of the precipitation of CA I and CA 
I HIR-1 by purified human CA I anti-CA I antibodies 
were carried out in 0.1 M Tris-SO, buffer at pH 7.0 and 
8.5. Ten microliters of the enzymes (0.2 mg/ml) and 10 ~1 of 
the purified CA I antibodies (3.0mg/ml) were added to 
400~1 of 0.1 M Tris-SO, buffer, and incubated at 37 and 
25°C. At various time intervals. aliquots were removed and 
centrifuged at 10,000 rpm for 2 min. The esterase activity of 
the supernatant was then measured to determine the extent 
of inhibition by antibody, 
Enzyme assays 
The esterase activities of the carbonic anhydrases were 
measured spectrophotometrically with p-nitrophenyl acet- 
ate as substrate by the method of Armstrong et al. (1966). 
For the inactivation and reactivation experiments. the 
assays were carried out in the presence of the same concen- 
tration of Gnd. HCI as in the reaction mixtures. 
The residual esterase activities in the immunoprecipita- 
tion experiments were measured by directly assaying the 
supernatant solutions. The esterase activities of the immu- 
noprecipitates were determined by first washing them 3 
times with 0.1 M Tris-SO, buffer, pH 7.5 or 8.0. brought to 
the initial buffer volume with the same buffer. and then 
vigorously shaking the solutions containing the immuno- 
precipitates on a Vortex mixer for 2 min. 
All esterase activities are presented as the percent of in- 
itial activity. 
RESULTS 
Inactivation and reactivation 
As shown in Fig. 1, the relative loss of esterase 
activity in 1.6 M Gnd HCl proceeded at a similar rate 
for both the normal and variant enzymes at 25’C. 
This was also true for concentrations of 1.5, 1.7 and 
2.0 M Gnd.HCI (data not shown). At 37”C, however, 
CA I HIR-1 (after 10min) exhibited about a 15% 
greater loss of activity than normal CA I in 1.5 M 
Gnd.HCl. A 1: 1 mixture of CA I and CA I HIR-1 
showed intermediate values. 
After denaturation in 5.0 M Gnd. HCl, the normal 
CA I isozymes recovered about 93 and 80% of their 
esterase activities in 20 min at protein concentrations 
of 0.1 and 0.4 mg/ml, respectively (Fig. 2). However, 
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Fig. 2. Time-course for the reactivation of normal CA I 
and CA I HIR-1 denatured in 5.0 M Gnd.HCI for 24 hr at 
25°C at various protein concentrations: CA I, 0.1 mg/ml 
(0); CA I, 0.4 mg/ml (m); CA I HIR-1, 0.17 mg/ml (0); CA 
I HIR-1, 0.35 mg/ml (0). See Materials and Methods for 
experimental details. 
esterase activity at concentrations of 0.35 and 
0.17 mg/ml, respectively. The presence of 1 mM di- 
thiothreitol in the reactivation buffer did not appear 
to alter the reactivation patterns of the normal and 
variant enzymes (data not shown). 
Immunoprecipitation analysis 
As seen in Fig. 3, the esterase activities of both CA 
I and CA I HIR-1 in the supernatants of the immu- 
noreaction mixtures decreased with increasing 
amounts of anti-CA I antibody, with no differences 
observed between the normal and variant enzymes at 
pH 7.5 and pH 8.0. Also, no obvious differences were 
seen in the esterase activities of the immunoprecipi- 
tates produced by the immunological reactions. 
In the time-course experiments (Fig. 4) no differ- 
ences were seen between the normal and variant 
enzymes in the esterase activities of the supernatants 
at pH 7.0 over a 40-min period. However, at pH 8.5, 
no further esterase activity in the supernatant was 
detected for CA I HIR-1 after 40 min, whereas normal 
CA I had about 10% of its relative activity remaining 
at the end of this same time period. 
DISCUSSION 
During the denaturation and reactivation experi- 
ments, it was shown that the CA I variant, CA I 
i;k& 
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Fig. 3. Precipitation of CA I and CA 1 HIR-1 by purified 
anti-CA I antibodies at pH 7.5 and 8.0. Esterase activity of 
supernatant solutions: CA I(O); CA I HIR-1 (0); esterase 
activity of immunoprecipitates: CA I (m); CA I HIR-1 (0). 
See Materials and Methods for procedural details. 
Reactivation studies of CA I Hiroshima-l 55.5 
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Fig. 4. Time-course for precipitation of CA I and CA I 
FUR-1 by purified anti-CA I antibodies. Esterase activity 
of sa~raatant soiutions: CA I, (@I; CA I HIR-I (0). See 
Mater~~s and Methods for procedural details. 
WIR-1, unfolded more rapidly than normai CA I 
under certain conditions (i.e. 37”C, pH 7.5, 1.5 M 
Gnd+HCI), and showed a lower level of reactivation 
under all of the experimental conditions. It thus 
appears from these pr~i~rni~~r~ findings that the sub- 
stitution of GLy for Asp at p~ition 86 in the WU%II~ 
CA I has the effect of reducing the e%ciency of the 
refolding process. Since residue 86 is on the outside of 
the human CA I molecute, and does not appear to be 
part of any secondary structure (cf. Notstrand el gI., 
197.5), no obvious mechanism is forth~orni~~ to 
explain the altered folding pattern. It has previously 
been reported that CA I HIR-1 is less the~m~st~ble 
than normal CA I (Kageoka ef al,, 1981). 
Since CA I HIR-1 appears to be more rapidly pre- 
cipitated than the normal enzyme, by the anti-CA I 
antibodies, it is pssibte that the Asp to Gly substitu- 
tion has somebo~ increased Fhe binding etficiency of 
an antigenie site or sites. Two ~ossib~litjes could 
account for such a change. Either residue 86 may 
itself be part of an antigenic reactive region, or the 
substitution might bring about a conformational 
change which could alter an antigenic site or sites at 
another part of the molecule. In this respect, Shapira 
& Ben-Yoseph (1976) demonstrated that about one 
haff of the a~t~g~n~~ sites of human CA I did not bind 
anti CA I antibodies in the presence of the substrate, 
HCO;. whereas fulf binding was observed with the 
substrates, CO, or p-nitrophenyl acetate. This finding 
suggests that a conformational change in the active 
site can produce changes in antigenic determinants 
that may be far removed from the active site. It wauld 
obviously be important to our understanding of these 
results if the antigenic d~termi~auts of human CA I 
couid be localized by methods similar to those used 
to determine the antigenic reactive regions of myoglo- 
bin (cf. Atassi. 1977). 
The meaning of these findings concerning the et%eect 
nf alterations in the primary structure of a protein on 
its reactivation characteristics and antigenic defer&n- 
ants should become clearer when more structural 
variants of red cell CA I are similarly examined. In 
this regard, it would be of particular interest to study 
the heat stable variant, CA I Michigan-~ 
(1OO Thr --‘+ Lys) (Osborne & Tashian, 19X), and vari- 
B.C. i4,%--tl 
ants which are present at lower levels than the normal 
enzyme such as the CA I variant, CA Ia, of the pigtail 
macaque, Mucaca ne~~srr~~. [i.e. 25% of normal 
levets) (DeSimone et al., 1973). 
If the folding effciency of CA I NIR-1 is also 
altered in &a, it is noteworthy that its synthesis in 
red cells is not decreased as it has been shown that 
both normal and variant enzymes are present in ap- 
~ro~~rnately equal amounts in hemoiysates of individ- 
uals that are heteroz~gous for the variant enzyme 
(Kageoka er al., 3981). As previously noted, it is of 
interest that the residue at position 86 is Asp in ali 
mammalian GA I isozymes sequenced to date (i.e. 
human, chimpanzee, orangutan, rhesus macaque and 
rabbit); however, in turtle CA I. the CA II isozymes of 
human, rhesus, sheep, ox and rabbit and the CA III 
isozymes of human and gorilla, the residue at this 
position is Gly (Kageoka et at., 1981, and references 
therein), It thus appears that Gly is the ancestral resi- 
due at position 86, and that the Asp --+ Gly substitu- 
tion represents a back mutation. 
SUMMARY 
Inactivation and reactivation studies and immuno- 
precipitation experiments were carried out on an 
inherited variant of red cell CA I, CA I HIR-I 
(86 Asp --+ Gly), ~revjous~y described from the 
Japanese ~~utat~oa. Under certain ~ondjtions, CA I 
HIR-1 was: (I) inactivated in Gnd. HCI more rapidly 
than normal CA 1; (2) reactivated more slowly than 
normal CA I after denaturation in 5.0 M Gnd*HCi; 
and (3) precipitated more rapidly than normal CA I 
by purified anti-CA i antibodies. 
The results suggest that the substitution of GIy for 
Asp at position 86 in human CA I (1) interferes with 
the efficiency of the refofding process and (2) that Gly 
at ~s~t~on 86 in CA I HIR-1 may have the effect of 
increasing the binding capacity of an antigenic reac- 
tive region or regions. 
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